We present four patients from South Africa with meningitis caused by Cryptococcus neoformans var. gattii, serotype C. These are the rst patients with human immunode ciency virus (HIV) infection to be reported with serotype C meningitis.
Introduction
The epidemiology of cryptococcosis has changed drastically with the acquired immunode ciency syndrome (AIDS) epidemic. This opportunistic infection occurs in 2-30% of patients infected with HIV, the highest incidences being recorded in Africa and Southeast Asia [1] . Cryptococcus neoformans has been divided into two varieties: C. neoformans var. neoformans (serotypes A and D) and C. neoformans var. gattii (serotypes B and C). C. neoformans var. gattii occurs mainly in tropical and subtropical climates [2, 3] . In 1990, Kwon-Chung and colleagues noticed that serotypes A and B, each of which used to infect approximately 50% of the patients before the AIDS epidemic, were distributed unevenly among AIDS patients, with serotype A responsible for the vast majority of the infections in these patients [4] . Rozenbaum and collaborators con rmed that C. n. var. gattii (serotype B) was responsible for infections mainly in immunocompetent hosts whereas C. n. var. neoformans (serotype A) was found in immunocompromised hosts [5] . It was later emphasized that serotype B is characterized by concurrent focal cerebral and pulmonary cryptococcomas and, in patients with meningitis, severe neurological sequelae, as distinct from infections seen in patients with C. n. var. neoformans infection [6] [7] [8] . Serotype C, however, has rarely been isolated outside Southern California [2] , and little is known about the clinical features related to infection with this serotype whatever the underlying condition of the patient is. Cryptococcosis is caused almost exclusively by serotypes A and D in patients with AIDS [4, 5, 9, 10] . AIDS-related cases due to serotype B have only been published as case reports of meningitis [11] [12] [13] [14] [15] [16] [17] [18] [19] or sometimes of infections limited to cryptococcal pneumonia [20] . There has been only one case report of infection with serotype C in an HIV-seropositive patient [14] . The organism was cultured from bronchoalveolar lavage uid from a woman with a non-resolving pneumonia and a CD4 count of 448 mm
¡3
. There have been no previous reports of serotype C meningitis.
We report here four patients with AIDS and meningitis caused by C. neoformans var. gattii, serotype C.
Methods
The study site was Chris Hani Baragwanath Hospital, a 3300-bed public university hospital situated in Soweto, Gauteng Province, South Africa. A retrospective record review identi ed all patients with C. n. var. gattii infection from January 1997 to June 1999. Their clinical, laboratory and radiological data were extracted from their medical records.
C. neoformans was identi ed by the presence of a capsule, ability to grow at 37 o C, production of brown colonies on Niger seed agar and use of the API 20C AUX system (bioMé rieux, Marcy l'Etoile, France). The isolates were biotyped using canavanine glycine bromothymol blue agar [21] . Isolates were stored at 4 o C in sterile water. Serotyping was later determined using an immuno uorescent assay with a monoclonal antibody speci c for capsular polysaccharide [22] .
Results
Between January 1997 and June 1999, 276 patients with cryptococcal infection were identi ed, of whom 226 (82%) were HIV-seropositive, four (1%) were HIVseronegative and 46 (17%) were not tested for HIV serostatus. All cryptococcal isolates were biotyped. Five patients were infected with C. n. var. gattii, including four with serotype C, of whom three were HIV-seropositive. There was one patient with serotype B and AIDS. The three HIV-infected subjects with serotype C meningitis constituted 1¢3% of the HIV-seropositives in this cohort. A fourth HIV-seropositive patient with serotype C was diagnosed in 1994. The HIV-seronegative person with serotype C resided in Venda, a subtropical region of Northern Province, South Africa. All four subjects with serotype C infection and AIDS had cryptococcal meningitis, were resident in Soweto and gave no histories of recent travel. Detailed geographical histories were not obtained. A diagnosis of AIDS was based on HIVseropositivity, very low CD4 cell counts (patients 1,3,and 4), tuberculosis (patients 2 and 3) and HIV wasting syndrome (patient 1).
The characteristics of the AIDS patients infected with C. n. var. gattii, serotype C, are presented in Table 1 . Weight loss, vomiting, photophobia and seizures were noted in two patients each. Patient 4 had concurrent cryptococcal fungaemia and a pulmonary in ltrate suggestive of cryptococcal pneumonia. No subject had skin lesions or a pulmonary or cerebral mass lesion documented. Two patients had an abnormal ocular presentation. The patients were treated with uconazole 400 mg orally daily for 10-12 weeks followed by 200 mg daily.
Discussion
Three reports have underlined differences between C. n. var. gattii and C. n. var. neoformans in terms of host infected and type of disease in Australian patients [6] [7] [8] . However C. n. var. gattii was in these cases synonymous with serotype B. Strangely enough, serotype C infections have rarely been reported in the literature. This can be explained either by the absence of clinical features speci c to this serotype or, more probably, to the lack of routine serotyping of clinical isolates. Died on day 8
Died on day 2
Details on two cases of meningitis due to serotype B in Zimbabwe were not available in the corresponding publication [19] and one case in Australia [8] .
NA, not available, ND, not done/not determined. The majority of patients with cryptococcal meningitis and AIDS are infected with C. n. var. neoformans in Southern Africa as in other parts of the world [19] . We were therefore surprised to discover that four patients with AIDS had cryptococcal meningitis due to C. neoformans serotype C. Since the characteristics of the infections due to serotype B differ from those with serotype A, we wondered if those caused by serotype C would be distinguishable from the former. The poor in ammatory response in the cerebrospinal uid was similar to that found in AIDS patients with C. n. var. neoformans meningitis. This could be in agreement with the conclusion from the Australasian Cryptococcal working group: that clinical manifestations of disease are more in uenced by host immune status than by cryptococcal variety [8] . AIDS patients with cryptococcal meningitis are noteworthy for the frequent lack of meningism and for a lack of in ammatory response in the cerebrospinal uid [23] . In addition, any patients infected with serotype B are known for a poor response to antifungal treatment [7, 24] . In comparison with patients with serotype B meningitis and AIDS, the clinical features of these AIDS patients with serotype C meningitis were noteworthy for the lack of fever on admission to hospital and for the fact that all survived beyond the hospital admission (Table 2) . However, follow-up was not prolonged enough to uncover possible sequelae, especially visual loss as in patients from Papua New Guinea infected with serotype B [24] . No patient had pulmonary or cerebral mass lesions, in contrast with immunocompetent patients with serotype B infections [6, 7] . Our series is too small to draw rm conclusions about the clinical presentation of serotype C meningitis in AIDS patients, but it may be possible to combine our data with those from other centres in the future. This is the second report of serotype C involvement in human infections in Africa and the rst instance where it has caused meningitis in AIDS patients. Soweto, which has a temperate climate, is the rst setting in which serotype C has accounted for > 1% of AIDS-related cryptococcal infections. Serotype C [I. W. Espie, personal communication] has recently been identi ed as having been responsible for meningoencephalitis in a captive king cheetah in our area [25] . The natural habitat of serotype C has not been established, although it has been isolated from almond trees (Terminalia catappa) in Colombia [26] . While Eucalyptus trees, which are associated with serotype B [27] , are found throughout South Africa, the distribution of almond trees is poorly documented. Environmental studies to de ne the distribution of C. n. var. gattii in South Africa remain to be performed.
